Growth at a Reasonable Price

Growth at a reasonable price (GARP) is an investment strategy that pursues stocks with strong earnings growth rates priced below the richest valuations of pure growth investors. Rather than chasing momentum at any price or value-trapping deep discounts, GARP investors seek the middle ground: companies expanding earnings faster than the market average, yet trading at multiples closer to the broader market or even their historical norms.

Why growth alone has never been enough

Pure growth investing has a long history of rewarding speculators until it doesn’t. A business growing earnings 25% annually is genuinely valuable, but overpaying for that growth—then watching the multiple compress when growth inevitably slows—destroys shareholder returns. GARP acknowledges that growth matters enormously, but insists on a margin of safety in the price paid. When a stock trading at 50 times earnings grows at 20%, the entry point matters as much as the growth trajectory.

The strategy gained prominence in the 1990s as a counterbalance to the speculative extremes of internet-stock mania, and it remains relevant because the tension between growth and valuation never disappears. A genuinely fast-growing firm might trade at 30× earnings while the market average hovers at 18×; a GARP investor asks whether that 12× multiple premium can be justified, or whether waiting for a correction makes more sense.

The core screening criteria

GARP typically combines two core filters. First, earnings growth: the company must expand earnings per share faster than the market average—often 15% to 25% annually—demonstrating a real competitive advantage or market expansion. Second, valuation discipline: the price-to-earnings-ratio should sit below the industry average or within one standard deviation of the company’s own historical median. Some GARP investors also layer in growth-adjusted multiples, dividing the P/E ratio by the growth rate to score relative value.

A third dimension—financial health—filters out value traps disguised as bargains. A GARP screen typically requires a strong balance-sheet with moderate debt-to-equity-ratio and positive free cash flow. This prevents buying the cheap stock that collapses next quarter due to balance-sheet stress.

Timing and horizon

GARP portfolios typically hold across the business cycle, with a focus on the 2–5 year horizon. This horizon is critical: it’s long enough for earnings growth to compound and reinvestment to drive value creation, but short enough that you’re not betting on terminal perpetuity. The strategy often overweights industries in the middle of their expansion cycles—mature sectors with surprising growth pockets, or young industries scaling past their hypergrowth phase into profitable maturity.

Because GARP avoids the furthest extremes on both axes (most-expensive and cheapest valuations), it often performs steadily across market regimes. During value rallies, it underperforms the deepest value stocks; during growth rallies, it lags the frothiest high-fliers. But it tends to capture strong returns when earnings actually materialise and price multiples normalise, which is frequent enough to make the strategy compelling.

Common pitfalls

GARP sounds simple—find decent growth at fair prices—but execution stumbles often. One is mistaking cyclical recovery for structural growth. A cyclical industry can report 30% earnings growth off a depressed base without ever being a high-growth business; confusing the two leads to overstaying a rebound. Another is overpaying for visibility: companies with crystal-clear near-term growth often command premiums precisely because that growth is obvious and priced in. Contrarian GARP investors look for less-obvious growth—a mature company seeing margin expansion, or an unglamorous sector entering a renewal phase.

A third mistake is sticking dogmatically to historical P/E anchors. If a company’s long-term growth rate genuinely accelerates—via a new market, product, or technology—its justified multiple rises. GARP isn’t about always paying the historical average; it’s about not paying 3–4 standard deviations above it without very strong conviction.

Sector and company-size flavours

GARP can work across market caps, though it has historically thrived in mid-cap and large-cap stocks where growth becomes genuinely surprising. Small-cap growth is often too volatile for GARP’s measured approach; micro-cap companies are either blazing past growth expectations or collapsing. GARP also leans toward industrials, healthcare, and technology—sectors where earnings growth is durable and somewhat predictable—and shuns very cyclical industries like commodities or hard-hit consumer discretionary plays.

Some GARP managers blend in dividend yields, preferring companies that return cash to shareholders whilst still reinvesting in growth. Others focus on free-cash-flow conversion, seeking companies that turn earnings growth into actual cash generation rather than inflated accounting profits.

Measuring success

A GARP portfolio should outpace the broad market over full market cycles, with lower volatility than pure growth and better returns than pure value. Historically, GARP has delivered roughly 10–12% annualised returns across decades, modestly ahead of the S&P 500 Index but with less headline-grabbing upside in bull markets. The real edge comes from avoiding catastrophic drawdowns: a GARP investor rarely owns the most-expensive 5% of the market, so when those valuations crack, the damage is contained.

The strategy’s effectiveness also depends on how carefully you distinguish growth from hype. A company in a genuinely expanding market with real competitive advantages and improving margins is a GARP candidate; a company with good short-term momentum and no structural edge is not. The discipline to say “no” to compelling stories lacking fundamental underpinning is what separates GARP from dressed-up momentum.

See also